Disease | glioblastoma |
Phenotype | C0028945|oligodendroglioma |
Sentences | 14 |
PubMedID- 24118308 | A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component. |
PubMedID- 24745708 | The diagnosis of glioma was established in 3 of 5 cases in which definitive diagnosis was not obtained using frozen sections, and information was obtained for the discrimination of glioblastoma or glioblastoma with an oligodendroglioma component from anaplastic glioma or secondary glioblastoma. |
PubMedID- 25500080 | glioblastoma (gbm) with oligodendroglioma component (gbmo) is a newly described gbm subtype in the 2007 world health organization classification. |
PubMedID- 26232204 | Introduction: the aim of this study is to investigate perfusion characteristics of glioblastoma with an oligodendroglioma component (gbmo) compared with conventional glioblastoma (gbm) using dynamic susceptibility contrast (dsc) perfusion magnetic resonance (mr) imaging and microvessel density (mvd). |
PubMedID- 23530875 | Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics. |
PubMedID- 25853013 | The use of 11c-4dst and 18f-flt as a pet tracer was approved by kagawa university, faculty of medicine human subjects ethical committees and informed consent was obtained from all patients before pet examination.table 1patient characteristics and pet datacase no.age (years)/sextumor typeaprimary/recurrenceki-67 index4dstfltsuvmaxt/n ratiosuvmaxt/n ratio164/fdaprimary10.531.710.572.71222/mdaprimary50.531.510.281.75346/maaprimary150.852.240.955.59473/maaprimary202.356.912.4114.18564/maoaprimary851.133.771.067.57669/fgbmprimary201.634.661.346.70739/fgbmprimary701.444.801.727.82876/fgbmprimary906.9518.293.2317.95972/fgbm-oprimary701.574.761.357.111034/maarecurrence222.249.331.8814.461173/maoarecurrence802.678.344.6820.351247/faoarecurrence351.524.341.787.741352/mgbmrecurrence152.806.092.5615.061446/mgbmrecurrence353.5010.943.5215.301529/fgbmrecurrence501.566.501.5213.821646/mgbmrecurrence703.118.643.1218.351729/fgbmrecurrence601.224.691.9513.931679/fgbmrecurrence401.904.631.947.461969/mgbmrecurrence51.524.471.458.062029/fgbm-orecurrence201.102.501.385.11ada: diffuse astrocytoma, aa: anaplastic astrocytoma, aoa: anaplastic oligoastrocytoma, gbm: glioblastoma, gbm-o: glioblastoma with oligodendroglioma component. |
PubMedID- 23289977 | glioblastoma with oligodendroglioma component (gbm-o): molecular genetic and clinical characteristics. |
PubMedID- 24387276 | Another report described an aggressive clinical phenotype (8-month overall survival) characterizing a pediatric glioblastoma with an oligodendroglioma component, displaying neither idh1/2 mutation nor 1p/19q co-deletion[40], which was clearly different from the case reported here. |
PubMedID- 25354913 | The most recent definition of glioblastoma with oligodendroglioma component (gbmo) assigned clinical significance to the observation of oligodendroglial foci within glioblastomas. |
PubMedID- 22326863 | glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome. |
PubMedID- 24022617 | The entire lesion was surgically removed and was found to be a glioblastoma with an extensive oligodendroglioma component. |
PubMedID- 25151507 | The subjectivity in pathological diagnosis of anaplastic oligoastrocytoma (aoa) and uncertainty in designation of glioblastoma with oligodendroglioma component (gbmo) were two major dilemmas which puzzled neuro-pathologists and neurosurgeons. |
PubMedID- 22911839 | The favorable prognosis of high-grade oligodendroglial tumor such as glioblastoma (gbm) with oligodendroglioma component (gbmo) has been suggested; however, the studies which examine the prognostic significance of oligodendroglial tumor were limited. |
PubMedID- 22736234 | On histopathological review, only one gbm was diagnosed as glioblastoma with oligodendroglioma component (gbmo). |
Page: 1